1. Is There Still a Market for Sanger Sequencing? Microdevice Developers Think So (from April 24)
2. Millipore to Buy Serologicals for $1.4B in Cash; Firm Hopes to 'Pursue New Markets,' Grow Eurasian Sales (from April 25)
3. Invitrogen Divests German BioReliance Manufacturing Unit to Investor Group; Business 'Not Aligned' With Invitrogen's Goals (from April 27)
4. Applera, Beckman Coulter Disclose Terms of Settlement for CE, PCR Suit; Licenses Will Cost Applera $35M and Beckman $20M (from April 27)
5. Pelican Life Sciences Secures $100M in VC Cash; Closes First Acquisition, Plans More (from April 25)